Acorda Therapeutics | Beneficio Bruto En Ventas



Gross Profit On Sales Cambio Fecha
Acadia Pharmaceuticals USD 223.92M 13.87M 2025-03
Agios Pharmaceuticals USD 7.64M 1.83M 2025-03
ALKERMES USD 257.31M 110.81M 2025-03
Amgen USD 5.54B 430M 2025-03
Arrowhead Research -173085000 2.55M 2024-12
Biogen USD 1.87B 44.1M 2024-12
BioMarin Pharmaceutical USD 593.59M 17.59M 2025-03
Cipla INR 45.41B 4.9B 2025-03
Clal Biotechnology ILS -857000 1.42M 2022-06
Compugen USD 796K 12.74M 2024-12
CSL USD 4.28B 939M 2024-12
Cytokinetics -160545000 81.19M 2024-09
Gilead Sciences USD 5.99B 17M 2024-12
GlaxoSmithKline GBP 5.59B 34M 2025-03
Grifols EUR 766.49M 39.74M 2024-12
Halozyme Therapeutics USD 216.46M 39.49M 2025-03
Insmed USD 71.54M 6.75M 2025-03
Ligand Pharmaceuticals USD 40.48M 509K 2025-03
MannKind USD 61.34M 2.17M 2025-03
Merck EUR 3.14B 46M 2025-03
Moderna USD 17M 403M 2025-03
Neurocrine Biosciences USD 618.4M 4.3M 2024-12
Novartis USD 10.23B 294M 2024-12
Pfizer USD 11.12B 987M 2025-03
Sanofi EUR 7.72B 2.36B 2025-03
Teva Pharmaceutical Industries USD 1.91B 206M 2025-03
Ultragenyx Pharmaceutical USD 110.63M 37.35M 2025-03
Vertex Pharmaceuticals USD 2.49B 109.3M 2024-12



Acorda Therapeutics Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Jul 2025.